CHANGE IN ALZHEIMER’S DISEASE BLOOD-BASED BIOMARKERS AND ASSOCIATIONS WITH BRAIN AMYLOID DEPOSITION

作者
James Russell Pike,Yifei Lü,Jinyu Chen,Keenan A. Walker,Kevin Sullivan,Michael E Griswold,Thomas H. Mosley,Priya Palta
出处
期刊:Innovation in Aging [University of Oxford]
卷期号:8 (Supplement_1): 2-2
标识
DOI:10.1093/geroni/igae098.0004
摘要

Abstract Blood-based biomarkers show promise as a noninvasive, inexpensive method for measuring Alzheimer’s disease pathology throughout the lifecourse. However, the prospective associations and discriminatory accuracy of these biomarkers at different stages of the lifecourse and among diverse, community-dwelling populations requires further investigation. Between 2014 and 2015, 329 dementia-free participants from the Atherosclerosis Risk in Communities Study underwent brain MRI and PET scans. Amyloid positivity was defined as a standardized uptake value ratio greater than 1.2. Stored plasma samples collected in midlife (1993-95, mean age 58.5 years) and late-life (2011-13, mean age 76.2 years) from a subsample of 259 participants were assayed in 2022. The assay quantified amyloid-β (Aβ)42/40, phosphorylated tau (p-Tau181), neurofilament light (NfL), and glial fibrillary acidic protein (GFAP). Logistic regression models estimated the association between plasma biomarkers from midlife and late-life and amyloid positivity in late-life. Receiver operating characteristic curves documented the discriminatory accuracy of the biomarkers. Assays from midlife were not associated with amyloid positivity in late-life. However, late-life measurements of Aβ42/40, p-Tau181, and GFAP and change per decade from midlife to late-life in p-Tau181 and GFAP were associated with greater odds of amyloid positivity. The greatest discriminatory accuracy was achieved by using all assays measured in midlife and late-life (AUC = 0.754), although the accuracy when using only late-life measures was comparable (AUC = 0.737). Additional longitudinal research is needed to determine whether changes in plasma biomarkers measured before an individual is amyloid positive can identify older adults at risk of developing Alzheimer’s disease.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
lq完成签到 ,获得积分10
2秒前
wangjue完成签到,获得积分10
5秒前
李健的小迷弟的应助被Vincent采纳,获得10
6秒前
7秒前
12秒前
wu完成签到 ,获得积分10
17秒前
JamesPei的应助被Vincent采纳,获得10
17秒前
苹果元灵完成签到,获得积分10
18秒前
18秒前
666666神花露水完成签到 ,获得积分10
21秒前
NexusExplorer的应助被Vincent采纳,获得10
24秒前
24秒前
yu完成签到 ,获得积分10
25秒前
31秒前
爆米花的应助被Vincent采纳,获得10
33秒前
37秒前
HAPPY完成签到,获得积分10
38秒前
桐桐的应助被Vincent采纳,获得10
39秒前
keleboys完成签到 ,获得积分10
41秒前
HMZ完成签到 ,获得积分10
43秒前
44秒前
HU完成签到 ,获得积分10
46秒前
47秒前
51秒前
小尾巴完成签到 ,获得积分10
54秒前
章鱼行者完成签到,获得积分10
54秒前
鲁文杰发布了新的文献求助10
55秒前
Maestro_S的应助被Vincent采纳,获得10
57秒前
58秒前
万能图书馆的应助被Vincent采纳,获得10
1分钟前
1分钟前
水静完成签到,获得积分10
1分钟前
川川完成签到 ,获得积分10
1分钟前
1分钟前
科研通AI6.4的应助被Vincent采纳,获得10
1分钟前
1分钟前
标致访旋完成签到,获得积分10
1分钟前
烂漫墨镜完成签到 ,获得积分10
1分钟前
20230054发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190366
求助须知:如何正确求助?哪些是违规求助? 9577437
关于积分的说明 21852521
捐赠科研通 7788988
什么是DOI,文献DOI怎么找? 3436315
关于科研通互助平台的介绍 2560144
邀请新用户注册赠送积分活动 2482995